Telogen elongation in the hair cycle of ob/ob mice

References

• Alonso L, Fuchs E. The hair cycle. J. Cell Sci. 2006;119:91–393.
   Web of Science ®Google Scholar
• O’goshi K, Iguchi M, Tagami H. Functional analysis of the stratum corneum of scalp skin: studies in patients with alopecia areata and androgenetic alopecia. Arch. Dermatol. Res. 2000;292:605–611.10.1007/s004030000185
   PubMed Web of Science ®Google Scholar
• Kanwar AJ, Narang T. Anagen effluvium. Indian J. Dermatol. Venereol. Leprol. 2013;79:604–612.10.4103/0378-6323.116728
   PubMed Web of Science ®Google Scholar
• Grover C, Khurana A. Telogen effluvium. Indian J. Dermatol. Venereol. Leprol. 2013;79:591–603.10.4103/0378-6323.116731
   PubMed Web of Science ®Google Scholar
• Bin Saif GA, McMichael A, Kwatra SG, Chan YH, Yosipovitch G. Central centrifugal cicatricial alopecia severity is associated with cowhage-induced itch. Br. J. Dermatol. 2013;168:253–256.
   PubMed Web of Science ®Google Scholar
• Cutrer FM, Pittelkow MR. Cephalalgic alopecia areata: a syndrome of neuralgiform head pain and hair loss responsive to botulinum A toxin injection. Cephalalgia. 2006;26:747–751.10.1111/cha.2006.26.issue-6
   PubMed Web of Science ®Google Scholar
• Willimann B, Trüeb RM. Hair pain (trichodynia): frequency and relationship to hair loss and patient gender. Dermatology. 2002;205:374–377.10.1159/000066437
   PubMed Web of Science ®Google Scholar
• Yamakoshi T, Andoh T, Makino T, Kuraishi Y, Shimizu T. Clinical and histopathological features of itch in patients with alopecia areata. Acta Derm. Venereol. 2013;93:575–576.10.2340/00015555-1613
   PubMed Web of Science ®Google Scholar
• de Hollanda TR, Ramos-e-Silva M, Sodre CT, Brasil M. Quality of life in alopecia areata: a case-control study. Int. J. Trichology. 2014;6:8–12.10.4103/0974-7753.136748
   PubMedGoogle Scholar
• Han SH, Byun JW, Lee WS, et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study. Ann. Dermatol. 2012;24:311–318.10.5021/ad.2012.24.3.311
   PubMed Web of Science ®Google Scholar
• McGarvey EL, Baum LD, Pinkerton RC, Rogers LM. Psychological sequelae and alopecia among women with cancer. Cancer Pract. 2001;9:283–289.10.1046/j.1523-5394.2001.96007.x
   PubMedGoogle Scholar
• Pickard-Holley S. The symptom experience of alopecia. Semin. Oncol. Nurs. 1995;11:235–238.10.1016/S0749-2081(05)80003-8
   PubMedGoogle Scholar
• Takashima I, Iju M, Sudo M. Alopecia androgenetica—its incidence in Japanese and associated condition. In: Orfanos CE, Montagna W, Stüttgen G, editors. Hair research. Berlin: Springer-Verlag; 1981. p. 287–293.10.1007/978-3-642-81650-5
   Google Scholar
• Jackow C, Puffer N, Hordinsky M, Nelson J, Tarrand J, Duvic M. Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J. Am. Acad. Dermatol. 1998;38:418–425.10.1016/S0190-9622(98)70499-2
   PubMed Web of Science ®Google Scholar
• Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin. Proc. 1995;70:628–633.10.4065/70.7.628
   PubMed Web of Science ®Google Scholar
• Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in Northern India. Int. J. Dermatol. 1996;35:22–27.
   PubMed Web of Science ®Google Scholar
• van der Steen P, Traupe H, Happle R, Boezeman J, Sträter R, Hamm H. The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate. Acta Derm. Venereol. 1992;72:373–375.
   PubMed Web of Science ®Google Scholar
• Yang S, Yang J, Liu JB, et al. The genetic epidemiology of alopecia areata in China. Br. J. Dermatol. 2004;151:16–23.10.1111/bjd.2004.151.issue-1
   PubMed Web of Science ®Google Scholar
• Trüeb RM. Chemotherapy-induced alopecia. Curr. Opin. Support Palliat. Care. 2010;4:281–284.10.1097/SPC.0b013e3283409280
   PubMedGoogle Scholar
• Piraccini BM, Alessandrini A. Androgenetic alopecia. G. Ital. Dermatol. Venereol. 2014;149:15–24.
   PubMed Web of Science ®Google Scholar
• Blumeyer A, Tosti A, Messenger A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J. Dtsch. Dermatol. Ges. 2011;9Suppl 6:S1–S57.10.1111/ddg.2011.9.issue-s6
   PubMed Web of Science ®Google Scholar
• Yoshitake T, Takeda A, Ohki K, et al. Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia. J. Dermatol. 2015;42:735–738. doi:10.1111/1346-8138.12890.
   PubMed Web of Science ®Google Scholar
• Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J. Clin. Invest. 1998;101:62–67.10.1172/JCI551
   PubMed Web of Science ®Google Scholar
• Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on prkdcscid mice. J. Invest. Dermatol. 2001;117:1357–1362.10.1046/j.0022-202x.2001.01583.x
   PubMed Web of Science ®Google Scholar
• Minematsu T, Nishijima Y, Huang L, et al. HSL attenuates the follicular oxidative stress and enhances the hair growth in ob/ob mice. Plast. Reconstr. Surg. Glob. Open. 2013;1:e60.10.1097/GOX.0000000000000000
   PubMedGoogle Scholar
• Sumikawa Y, Inui S, Nakajima T, Itami S. Hair cycle control by leptin as a new anagen inducer. Exp. Dermatol. 2014;23:27–32.10.1111/exd.12286
   PubMed Web of Science ®Google Scholar
• Paus R, Müller-Röver S, van der Veen C, et al. A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J. Invest. Dermatol. 1999;113:523–532.10.1046/j.1523-1747.1999.00740.x
   PubMed Web of Science ®Google Scholar
• Dry FW. The coat of the mouse (Mus musculus). J. Genet. 1926;16:287–340.10.1007/BF02983004
   Google Scholar
• Yang CC, Sheu HM, Chung PL, et al. Leptin of dermal adipose tissue is differentially expressed during the hair cycle and contributes to adipocyte-mediated growth inhibition of anagen- phase vibrissa hair. Exp. Dermatol. 2014;24:57–60.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–432.10.1038/372425a0
   PubMed Web of Science ®Google Scholar
• Dubuc PU. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism. 1976;25:1567–1574.10.1016/0026-0495(76)90109-8
   PubMed Web of Science ®Google Scholar
• Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J. Hered. 1950;41:317–318.
   PubMed Web of Science ®Google Scholar
• Acibucu F, Kayatas M, Candan F. The association of insulin resistance and metabolic syndrome in early androgenetic alopecia. Singapore Med. J. 2010;51:931–936.
   PubMed Web of Science ®Google Scholar
• Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J. Am. Acad. Dermatol. 2010;63:420–429.10.1016/j.jaad.2009.10.018
   PubMed Web of Science ®Google Scholar
• Yang CC, Hsieh FN, Lin LY, Hsu CK, Sheu HM, Chen W. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. J. Am. Acad. Dermatol. 2014;70:297–302.e1.10.1016/j.jaad.2013.09.036
   PubMed Web of Science ®Google Scholar
• Ibuki A, Akase T, Nagase T, et al. Skin fragility in obese diabetic mice: possible involvement of elevated oxidative stress and upregulation of matrix metalloproteinases. Exp. Dermatol. 2012;21:178–183.10.1111/exd.2012.21.issue-3
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Ibuki A, Minematsu T, et al. Structural changes in dermal collagen and oxidative stress levels in the skin of Japanese overweight males. Int. J. Cosmet. Sci. 2014;36:477–484.10.1111/ics.2014.36.issue-5
   PubMed Web of Science ®Google Scholar
• Nagase T, Akase T, Sanada H, et al. Aging-like skin changes in metabolic syndrome model mice are mediated by mineralocorticoid receptor signaling. Aging Cell. 2013;12:50–57.10.1111/acel.12017
   PubMed Web of Science ®Google Scholar
• Sainte Marie Y, Toulon A, Paus R, et al. Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia. Am. J. Pathol. 2007;171:846–860.10.2353/ajpath.2007.060991
   PubMed Web of Science ®Google Scholar
• Abdel Fattah NS. Ebrahim AA, El Okda ES. Lipid peroxidation/antioxidant activity in patients with alopecia areata. J. Eur. Acad. Dermatol. Venereol. 2011;25:403–408.
   PubMed Web of Science ®Google Scholar
• Bahta AW, Farjo N, Farjo B, Philpott MP. Premature senescence of balding dermal papilla cells in vitro is associated with p16 (INK4a) expression. J. Invest. Dermatol. 2008;128:1088–1094.10.1038/sj.jid.5701147
   PubMed Web of Science ®Google Scholar
• Katagiri K, Arakawa S, Hatano Y, Fujiwara S. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata. J. Dermatol. 2006;33:75–79.10.1111/jde.2006.33.issue-2
   PubMed Web of Science ®Google Scholar